<DOC>
	<DOCNO>NCT00001040</DOCNO>
	<brief_summary>PRIMARY : To determine efficacy toxicity three treatment regimen : saquinavir mesylate ( Ro 31-8959 ) plus zidovudine ( AZT ) vs. AZT plus zalcitabine ( dideoxycytidine ; ddC ) vs. Ro 31-8959 plus AZT plus ddC . SECONDARY : To investigate pharmacokinetics effect various clinical parameter three regimen .</brief_summary>
	<brief_title>Comparison Ro 31-8959 Plus Zidovudine ( AZT ) Versus AZT Plus Zalcitabine ( ddC ) Versus Ro 31-8959 Plus AZT Plus ddC</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Zalcitabine</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>Inclusion Criteria Prior Medication : Required : At least 4 month total AZT point past , alone combination antiretroviral therapy . Patients must : HIV seropositivity . Diagnosis AIDS , ARC , PGL , asymptomatic infection . CD4 count &gt; 50 &lt; = 300 cells/mm3 . Life expectancy least 6 month . Prior AZT therapy . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Acute serious opportunistic infection require immediate treatment , include ( limited ) tuberculosis , CMV , cryptococcal meningitis , disseminate MAC , cerebral toxoplasmosis , Pneumocystis carinii pneumonia . Known intolerance Ro 318959 , AZT , ddC . Symptoms suggestive pancreatitis . Moderate severe peripheral neuropathy evidence discomfort numbness , tingle , burn pain extremity relate symptom accompany objective finding . Visceral Kaposi 's sarcoma . Lymphoma require therapy within next 6 month . Transfusion dependence . Concurrent Medication : Excluded : Investigational antineoplastic agent . Concurrent Treatment : Excluded : Radiotherapy ( local skin radiotherapy ) . Transfusions . Prior Medication : Excluded : Any antiretroviral agent ( AZT ) immunomodulatory therapy within 14 day prior study entry . Prior treatment HIV proteinase inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Zalcitabine</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Saquinavir</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
</DOC>